Tesamorelin Reconstitution Calculator

What this page converts

Mass of lyophilized peptide in a vial and the volume of diluent added determine concentration:

• mg/mL = vial mass (mg) ÷ diluent volume (mL)
• mcg/mL = mg/mL × 1,000

The page does not convert a chosen mass into a draw volume, and it does not publish a treatment schedule.

Research context

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It is the only GHRH analog with FDA approval, granted in 2010 under the brand name Egrifta for reduction of excess visceral adipose tissue in adults with HIV-associated lipodystrophy — not general fat loss.

Approved Egrifta products have manufacturer reconstitution in the FDA prescribing information. Those instructions govern the approved product and are not interchangeable with a generic mass-volume example. See the tesamorelin dossier.

What the conversion uses

1. Vial mass in milligrams from the label or certificate of analysis.
2. Diluent volume in milliliters.

The only result is concentration (mg/mL or mcg/mL).

Notes

• Unit labels differ. Confirm whether the vial lists mg or mcg before converting.
• Reconstituted solutions degrade faster than lyophilized powder. Storage conditions belong to the manufacturer or study materials, not this page.

Related resources

• Tesamorelin Dossier — evidence-graded research summary
• Tesamorelin Safety Profile — adverse events and monitoring
• Reconstitution Glossary — general technique and definitions
• Bacteriostatic Water — diluent properties
• Lyophilization — why peptides are freeze-dried